Patents by Inventor Linli Wei

Linli Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS
    Publication number: 20220396588
    Abstract: Compounds of the formulas which are useful as colony stimulating factor-1 receptor inhibitors (“CSF-1R inhibitors”).
    Type: Application
    Filed: February 9, 2022
    Publication date: December 15, 2022
    Applicant: Genzyme Corporation
    Inventors: John L. Kane, JR., Claude Barberis, Mark Czekaj, Paul Erdman, Barret Giese, Michael Kothe, Tieu-Binh Le, Jinyu Liu, Liang Ma, Markus Metz, Vinod Patel, Andrew Scholte, Patrick Shum, Linli Wei
  • Colony stimulating factor-1 receptor (CSF-1R) inhibitors
    Patent number: 11274108
    Abstract: Compounds of the formulas which are useful as colony stimulating factor-1 receptor inhibitors (“CSF-1R inhibitors”).
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: March 15, 2022
    Assignee: GENZYME CORPORATION
    Inventors: John L. Kane, Jr., Claude Barberis, Mark Czekaj, Paul Erdman, Barret Giese, Michael Kothe, Tieu-Binh Le, Jinyu Liu, Liang Ma, Markus Metz, Vinod Patel, Andrew Scholte, Patrick Wai-Kwok Shum, Linli Wei
  • COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS
    Publication number: 20190016707
    Abstract: Compounds of the formulas which are useful as colony stimulating factor-1 receptor inhibitors (“CSF-1R inhibitors”).
    Type: Application
    Filed: July 19, 2016
    Publication date: January 17, 2019
    Inventors: John L. KANE, Jr., Claude Barberis, Mark Czekaj, Paul Erdman, Barret Giese, Michael Kothe, Tieu-Binh Le, Jinyu Liu, Liang Ma, Markus Metz, Vinod Patel, Andrew Scholte, Patrick Wai-Kwok Shum, Linli Wei
  • Compounds useful as chemokine receptor antagonists
    Patent number: 8399455
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: March 19, 2013
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Gerard Rosse, Linli Wei, Kenneth G. Carson
  • Pyrazolopyridine derivatives as inhibitors of ?-Adrenergic receptor kinase 1
    Patent number: 7910602
    Abstract: The invention relates to 6-amido substituted pyrazolopyridine derivatives of the formula (I) useful as inhibitors of beta-adrenergic receptor kinase 1 (?ARK-1), compositions containing such compounds and their use for the treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: March 22, 2011
    Assignee: Sanofi-Aventis
    Inventors: Henning Steinhagen, Jochen Huber, Kurt Ritter, Bernard Pirard, Kirsten Bjergarde, Marcel Patek, Martin Smrcina, Linli Wei
  • COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS
    Publication number: 20100234356
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
    Type: Application
    Filed: October 13, 2009
    Publication date: September 16, 2010
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Gerard Rosse, Linli Wei, Kenneth G. Carson
  • Compounds useful as chemokine receptor antagonists
    Patent number: 7635698
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: December 22, 2009
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Gerard Rosse, Linli Wei, Kenneth G. Carson
  • Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1
    Publication number: 20080227777
    Abstract: The invention relates to 6-amido substituted pyrazolopyridine derivatives of the formula (I) useful as inhibitors of beta-adrenergic receptor kinase 1 (?ARK-1), compositions containing such compounds and their use for the treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction.
    Type: Application
    Filed: December 20, 2007
    Publication date: September 18, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Henning STEINHAGEN, Jochen HUBER, Kurt RITTER, Bernard PIRARD, Kirsten BJERGARDE, Marcel PATEK, Martin SMRCINA, Linli WEI
  • Compounds useful as chemokine receptor antagonists
    Publication number: 20060189628
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
    Type: Application
    Filed: December 28, 2005
    Publication date: August 24, 2006
    Inventors: Gerard Rosse, Linli Wei, Kenneth Carson